Recovery act tissue samples and data from various types of cancer for the cancer genome atlas (tcga) program
Ended Awarded Last action
- Contract number
- HHSN261201000009I
- Awardee
-
Indivumed, Inc. UEI L5JBA83NAK17
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 3 $2,259,118 obligated
Award facts
- Opportunity
-
- RFQNCI10006AS Solicitation number
- RECOVERY - Tissue Purchase Order Contract Acquisitions for NCI's The Cancer Genome Atlas Program Award Notice · Posted Dec 4, 2009
- Combined order value
- $2,259,118 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 83% used
- $2,712,155.00
- Maximum order
- $2,674,155.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 6 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Indivumed, Inc. to provide tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The contract has a total ceiling value of $2,712,155.00 and does not have a set-aside designation.
The contract consists of three firm-fixed-price delivery orders with a combined total value of $2,259,118.07. The orders require Indivumed to recover tissue samples and data from various cancer types to support the TCGA program, a major cancer research initiative led by NCI. The work is to be performed in Kensington, Maryland, and the period of performance extends through September 2014. This indefinite delivery contract serves as the parent vehicle for the individual delivery orders, allowing NCI to acquire the necessary tissue samples and data on an as-needed basis to advance the TCGA program's cancer research objectives.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN261201000009I?
HHSN261201000009I was awarded to Indivumed, Inc. by National Cancer Institute (National Institutes of Health) on January 25, 2010.
How much is contract HHSN261201000009I worth?
Orders under HHSN261201000009I have obligated $2,259,118. HHSN261201000009I's own ceiling is $2,712,155. A single order can be worth up to $2,674,155.
How many orders have been placed under contract HHSN261201000009I?
3 orders have been placed under HHSN261201000009I, the latest on July 7, 2010.
Who can order from contract HHSN261201000009I?
HHSN261201000009I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN261201000009I part of a contract vehicle?
Yes. HHSN261201000009I is part of NCI Cancer Genome Atlas Program Tissue Purchase.
Was contract HHSN261201000009I competed?
The extent of competition for HHSN261201000009I was competed under sap. The government received 6 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV